Search company, investor...

Predict your next investment

Holding Company
mentorcapital.com

Investments

27

Portfolio Exits

4

About Mentor Capital

Mentor Capital targets warrant proceeds for operating cancer companies often like those in the Cancer Immunotherapy Index and to invest in those or related firms via stock purchase or acquisition. The company's advantage is to seek in depth medical science judgment to screen cancer breakthroughs for probable success well in advance of the FDA process. In the Mentor program, an identified cancer company enters into a Long-term Equity Funding Agreement with the company. The company receives cancer related shares that are held in escrow until the associated investment payable is retired. The cancer fighting company receives cash from warrant proceeds at an agreed upon fixed price. The mutually related funding contracts speed up payment to the cancer companies growing most quickly.

Headquarters Location

P.O. Box 1709

Ramona, California, 92065,

United States

760-788-4700

Want to inform investors similar to Mentor Capital about your company?

Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.

Latest Mentor Capital News

Mentor Capital Harvests Half of Market Value in Cash from Side Investments and Reports 30% Q3 Sales Growth

Nov 22, 2022

PLANO, Texas–(BUSINESS WIRE)–Mentor Capital, Inc. (OTCQB: MNTR) announced 25% annualized sales growth to $7,472,367 for the trailing twelve months or $0.33 per share against a share price of $0.05 per share in its quarterly Form 10-Q filing for the third quarter ended September 30, 2022, filed with the Securities and Exchange Commission. During and subsequent […]

Mentor Capital Investments

27 Investments

Mentor Capital has made 27 investments. Their latest investment was in eShiksa as part of their Seed VC on March 3, 2019.

CBI Logo

Mentor Capital Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

3/29/2019

Seed VC

eShiksa

Yes

1

9/14/2018

Unattributed - III

GFarmaLabs

$0.25M

No

1

2/12/2018

Corporate Minority

Pueblo West Organics

Yes

2

1/16/2018

Unattributed - II

Subscribe to see more

$99M

Subscribe to see more

10

5/2/2017

Loan

Subscribe to see more

Subscribe to see more

10

Date

3/29/2019

9/14/2018

2/12/2018

1/16/2018

5/2/2017

Round

Seed VC

Unattributed - III

Corporate Minority

Unattributed - II

Loan

Company

eShiksa

GFarmaLabs

Pueblo West Organics

Subscribe to see more

Subscribe to see more

Amount

$0.25M

$99M

New?

Yes

No

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

1

1

2

10

10

Mentor Capital Portfolio Exits

4 Portfolio Exits

Mentor Capital has 4 portfolio exits. Their latest portfolio exit was AEP Networks on September 30, 2011.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

9/30/2011

Acquired

$99M

6/8/2009

Acquired

Subscribe to see more

$99M

Subscribe to see more

0

1/23/2006

Acquired

Subscribe to see more

$99M

Subscribe to see more

0

12/14/2001

Acquired

Subscribe to see more

$99M

Subscribe to see more

0

Date

9/30/2011

6/8/2009

1/23/2006

12/14/2001

Exit

Acquired

Acquired

Acquired

Acquired

Companies

Subscribe to see more

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

Acquirer

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

0

0

0

Mentor Capital Acquisitions

3 Acquisitions

Mentor Capital acquired 3 companies. Their latest acquisition was Cannabis Investor Webcast on April 22, 2015.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

4/22/2015

$99M

Acquired

1

3/11/2014

Subscribe to see more

$99M

Subscribe to see more

10

2/20/2014

Subscribe to see more

$99M

Subscribe to see more

10

Date

4/22/2015

3/11/2014

2/20/2014

Investment Stage

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

Total Funding

Note

Acquired

Subscribe to see more

Subscribe to see more

Sources

1

10

10

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.